Martin C Michel, M.D., is a Professor of Pharmacology at Johannes Gutenberg University Mainz in Germany and a Senior Advisor to a Venture Capital fund (INKEF). He was the Global Head of Product & Pipeline Scientific Support at Boehringer Ingelheim during 2011 – 2016, and Professor and Head of Department of Pharmacology and Pharmacotherapy at the University of Amsterdam from 2003 to 2011. Dr. Michel received many honors and awards including election to the Academia Europaea, the European academy of science. He was or is the Editor-in-Chief or Associate Editor for numerous top international journals including Pharmacological Reviews, Naunyn-Schmiedeberg’s Archives of Pharmacology, Molecular Pharmacology, Frontiers in Pharmacology, and Scientific Reports. He published more than 500 articles in peer-reviewed journals. Currently Dr. Michel serves as a Scientific Advisory Board member for several early-stage biotech companies across US and Europe focusing on various therapeutic areas including Oncology.